| Tumor-infiltrating mast cells are associated with resistance to anti-PD-1 therapy R Somasundaram, T Connelly, R Choi, H Choi, A Samarkina, L Li, ... Nature communications 12 (1), 346, 2021 | 154 | 2021 |
| Very low mutation burden is a feature of inflamed recurrent glioblastomas responsive to cancer immunotherapy M Gromeier, MC Brown, G Zhang, X Lin, Y Chen, Z Wei, N Beaubier, ... Nature communications 12 (1), 352, 2021 | 115 | 2021 |
| Diverse clonal fates emerge upon drug treatment of homogeneous cancer cells Y Goyal, GT Busch, M Pillai, J Li, RH Boe, EI Grody, M Chelvanambi, ... Nature 620 (7974), 651-659, 2023 | 93 | 2023 |
| Narrmda: Negative-aware and rating-based recommendation algorithm for mirna–disease association prediction L Peng, Y Chen, N Ma, X Chen Molecular BioSystems 13 (12), 2650-2659, 2017 | 22 | 2017 |
| Melanoma-intrinsic NR2F6 activity regulates antitumor immunity H Kim, Y Feng, R Murad, J Pozniak, C Pelz, Y Chen, B Dalal, R Sears, ... Science Advances 9 (27), eadf6621, 2023 | 6 | 2023 |
| The SET oncoprotein promotes estrogen-induced transcription by facilitating establishment of active chromatin C Guo, KF Meza-Sosa, D Valle-Garcia, G Zhao, K Gao, L Yu, H Zhang, ... Proceedings of the National Academy of Sciences 120 (8), e2206878120, 2023 | 2 | 2023 |
| Dasatinib Resensitizes MAPK Inhibitor Efficacy in Standard-of-Care Relapsed Melanomas VW Rebecca, M Xiao, A Kossenkov, T Godok, GS Brown, D Fingerman, ... bioRxiv, 2023 | 2 | 2023 |
| A pan-cancer patient-derived xenograft histology image repository with genomic and pathologic annotations enables deep learning analysis BS White, XY Woo, S Koc, T Sheridan, SB Neuhauser, S Wang, YA Evrard, ... Cancer research 84 (13), 2060-2072, 2024 | 1 | 2024 |
| PD-L1 in Melanoma and Extracellular Vesicles Promotes Local and Regional Immune Suppression through M2-like Macrophage Polarization L Huang, J Yang, J Zhu, H Wang, L Dong, Y Guo, Y Chen, F Zhang, DJ Xu, ... The American Journal of Pathology, 2024 | | 2024 |
